SMTL ID : 7aem.1

Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

monomer

Ligands

1 x 6GY: 5-chloro-N~4~-[2-(dimethylphosphoryl)phenyl]-N~2~-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine(Non-covalent)

6GY.1: 14 residues within 4Å: Chain A: L.42, G.43, F.47, V.50, A.67, T.114, Q.115, L.116, M.117, P.118, G.120, E.128, R.165, L.168 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.42, A:L.42, A:F.47, A:V.50, A:V.50 Hydrogen bonds: A:M.117, A:M.117 Salt bridges: A:E.128

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Floch, N. et al., Abstract 4451: Evaluation of the therapeutic potential of phosphine oxide pyrazole inhibitors in tumors harboring EGFR C797S mutation. Cancer Res. (2019)

Release Date

2021-04-07

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor